{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:59:15Z","timestamp":1648749555607},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T00:00:00Z","timestamp":1345161600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2458-12-670","type":"journal-article","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T12:14:41Z","timestamp":1345205681000},"source":"Crossref","is-referenced-by-count":1,"title":["The effect of tuberculosis and antiretroviral treatment on CD4+ cell count response in HIV-positive tuberculosis patients in Mozambique"],"prefix":"10.1186","volume":"12","author":[{"given":"Miranda","family":"Brouwer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Samu","family":"Gudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chalice Mage","family":"Simbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Perdig\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"van Leth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,17]]},"reference":[{"key":"4415_CR1","unstructured":"World Health Organization Report 2009 Global Tuberculosis Control. Surveillance, Planning, Financing. 2009, WHO\/HTM\/TB, 411-"},{"issue":"10","key":"4415_CR2","first-page":"894","volume":"5","author":"A Mac-Arthur Jr","year":"2009","unstructured":"Mac-Arthur A, Gloyd S, Perdig\u00e3o P, Noya A, Sacarlal J, Kreiss J: Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. Int J Tuberc Lung Dis. 2009, 5 (10): 894-902.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4415_CR3","volume-title":"Programa Nacional de Controle das ITS\/HIV\/SIDA. Ronda de Vigil\u00e2ncia epidemiol\u00f3gica do HIV de","author":"Minist\u00e9rio de Sa\u00fade da Rep\u00fablica de Mo\u00e7ambique","year":"2007","unstructured":"Minist\u00e9rio de Sa\u00fade da Rep\u00fablica de Mo\u00e7ambique: Departemento Nacional da Assist\u00eancia M\u00e9dica. Programa Nacional de Controle das ITS\/HIV\/SIDA. Ronda de Vigil\u00e2ncia epidemiol\u00f3gica do HIV de. 2007"},{"issue":"5","key":"4415_CR4","first-page":"579","volume":"8","author":"R Chimzizi","year":"2004","unstructured":"Chimzizi R, Gausi F, Bwanali A, Mbalume D, Teck R, Gomani P, Zachariah R, Zuza W, Malombe R, Salaniponi FM, Harries AD: Voluntary counselling, HIV testing and adjunctive cotrimoxazole are associated with improved TB treatment outcomes under routine conditions in Thyolo District, Malawi. Int J Tuberc Lung Dis. 2004, 8 (5): 579-585.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"4415_CR5","first-page":"285","volume":"57","author":"A Mwinga","year":"2008","unstructured":"Mwinga A, Mwananyambe N, Kanene C, Bulterys M, Phiri C, Kapata N, Mukonka V, Nadol P, Patel M, Nakashima A: Provider-initiated HIV testing and counseling of TB patients - Livingstone District, Zambia, September 2004-December 2006. MMWR Morb Mortal Wkly Rep. 2008, 57 (11): 285-289.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4415_CR6","volume-title":"Interim policy on collaborative TB\/HIV activities","author":"World Health Organization","year":"2004","unstructured":"World Health Organization: Interim policy on collaborative TB\/HIV activities. 2004, WHO\/HTM\/TB\/2004.330"},{"key":"4415_CR7","volume-title":"Tratamento antiretroviral e infec\u00e7\u00f5es oportunistas adulto e adolescente","author":"Minist\u00e9rio de Sa\u00fade","year":"2006","unstructured":"Minist\u00e9rio de Sa\u00fade: Tratamento antiretroviral e infec\u00e7\u00f5es oportunistas adulto e adolescente. 2006"},{"key":"4415_CR8","volume-title":"Rapid advice Antiretroviral therapy for HIV infection in adults and adolescents","author":"World Health Organization","year":"2009","unstructured":"World Health Organization: Rapid advice Antiretroviral therapy for HIV infection in adults and adolescents. 2009"},{"key":"4415_CR9","volume-title":"Guia de tratamento antiretroviral e infec\u00e7\u00f5es oportunistas no adulto, adolescente e gr\u00e1vida","author":"Minist\u00e9rio de Sa\u00fade","year":"2009","unstructured":"Minist\u00e9rio de Sa\u00fade: Guia de tratamento antiretroviral e infec\u00e7\u00f5es oportunistas no adulto, adolescente e gr\u00e1vida. 2009"},{"issue":"5","key":"4415_CR10","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/clinids\/24.5.988","volume":"24","author":"BE Jones","year":"1997","unstructured":"Jones BE, Oo MM, Taikwel EK, Qian D, Kumar A, Maslow ER, Barnes PF: CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis. 1997, 24 (5): 988-991. 10.1093\/clinids\/24.5.988.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4415_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/00042560-199504000-00010","volume":"8","author":"DJ Martin","year":"1995","unstructured":"Martin DJ, Sim JG, Sole GJ, Rymer L, Shalekoff S, van Niekerk AB, Becker P, Weilbach CN, Iwanik J, Keddy K, Miller GB, Ozbay B, Ryan A, Viscovic T, Woolf M: CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol. 1995, 8 (4): 386-391.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"12","key":"4415_CR12","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1086\/375346","volume":"187","author":"L Morris","year":"2003","unstructured":"Morris L, Martin DJ, Bredell H, Nyoka SN, Sacks L, Pendle S, Page-Shipp L, Karp CL, SterlingTR QTC, Chaisson RE: Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. J Infect Dis. 2003, 187 (12): 1967-1971. 10.1086\/375346.","journal-title":"J Infect Dis"},{"key":"4415_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1023\/B:EJEP.0000036572.00663.f2","volume":"19","author":"JW Twisk","year":"2004","unstructured":"Twisk JW: Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol. 2004, 19: 769-776.","journal-title":"Eur J Epidemiol"},{"issue":"9417)","key":"4415_CR14","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(04)15997-7","volume":"363","author":"F Van Leth","year":"2004","unstructured":"Van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, Gazzard B, Cahn P, Lalloo UG, van der Westhuizen IP, Malan DR, Johnson MA, Santos BR, Mulcahy F, Woord R, Levi GC, Reboredo G, Squires K, Cassetti I, Petit D, Raffi F, Katlama C, Murphy RL, Horban A, Dam JP, Hassink E, van Leeuwen R, Robinson P, Wit FW, Lange JM, 2 NN study team: Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet. 2004, 363 (9417)): 1253-1263.","journal-title":"Lancet"},{"key":"4415_CR15","first-page":"313","volume-title":"Guidelines for national programmes","author":"World Health Organization (2003) Treatment of Tuberculosis","year":"2003","unstructured":"World Health Organization (2003) Treatment of Tuberculosis: Guidelines for national programmes. 2003, WHO\/CDS\/TB, 313-3","edition":"3"},{"issue":"1","key":"4415_CR16","first-page":"3","volume":"21","author":"S Swaminathan","year":"2008","unstructured":"Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, Ponnuraja C, Dilip M: Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. Natl Med J India. 2008, 21 (1): 3-8.","journal-title":"Natl Med J India"},{"issue":"5","key":"4415_CR17","doi-asserted-by":"publisher","first-page":"e10527","DOI":"10.1371\/journal.pone.0010527","volume":"5","author":"SM Hermans","year":"2010","unstructured":"Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AIM, Manabe YC: Incident Tuberculosis during Antiretroviral Therapy Contributes to Suboptimal Immune Reconstitution in a Large Urban HIV Clinic in Sub-Saharan Africa. PLoS One. 2010, 5 (5): e10527-10.1371\/journal.pone.0010527.","journal-title":"PLoS One"},{"key":"4415_CR18","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","volume":"0","author":"SD Lawn","year":"2006","unstructured":"Lawn SD, Myer L, Bekker LG, Wood R: Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006, 0: 1605-1612.","journal-title":"AIDS"},{"key":"4415_CR19","volume-title":"No time to quit: HIV\/AIDS treatment gap widening in Africa. Analysis of the widening funding gap for HIV\/AIDS treatment in sub-Saharan Africa","author":"M\u00e9decins Sans Fronti\u00e8res","year":"2010","unstructured":"M\u00e9decins Sans Fronti\u00e8res: No time to quit: HIV\/AIDS treatment gap widening in Africa. Analysis of the widening funding gap for HIV\/AIDS treatment in sub-Saharan Africa. 2010"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-12-670\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T18:52:44Z","timestamp":1468349564000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-12-670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,17]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["4415"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-12-670","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,17]]},"article-number":"670"}}